Evidence map›Paper›PMID 40297856›Full record

ArticleFrontiers in neurology2025

Fluctuating or progressive hearing loss in the middle-to-high frequencies may suggest the neurotologic endotype of perilymphatic fistula without antecedent traumatic events.

Han Matsuda, Yukihide Maeda, Tomoyasu Kitahara, Masafumi Sawada, Hiroe Kudo, Kei Sakamoto, Atsuya Takayama, Tetsuo Ikezono

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Han MatsudaDepartment of Otorhinolaryngology, Saitama Medical University, Saitama, Japan.
Yukihide MaedaDepartment of Otorhinolaryngology, Saitama Medical University, Saitama, Japan.
Tomoyasu KitaharaDepartment of Otorhinolaryngology, Saitama Medical University, Saitama, Japan.
Masafumi SawadaDepartment of Otorhinolaryngology, Saitama Medical University, Saitama, Japan.
Hiroe KudoDepartment of Otorhinolaryngology, Saitama Medical University, Saitama, Japan.
Kei SakamotoDepartment of Otorhinolaryngology, Saitama Medical University, Saitama, Japan.
Atsuya TakayamaDepartment of Otorhinolaryngology, Saitama Medical University, Saitama, Japan.
Tetsuo IkezonoDepartment of Otorhinolaryngology, Saitama Medical University, Saitama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Idiopathic sudden sensorineural hearing loss (ISSNHL) is a common clinical condition. Recent studies indicate that approximately 20% of ISSNHL cases may involve perilymphatic fistula (PLF). The detection of Cochlin-tomoprotein (CTP) in middle-ear lavage samples confirms the diagnosis of PLF. Aims/Objectives: To clarify the clinical characteristics of inner ear-related symptoms in patients with PLF who lacked any antecedent traumatic events prior to symptom onset. Materials and methods: We retrospectively reviewed clinical records and CTP test results in 769 cases from 70 hospitals in Japan. Results: Among these cases, 204 had no history of antecedent events. CTP-positive findings were more frequently observed in patients exhibiting fluctuating and/or progressive hearing loss than in those without these symptoms ( Conclusions and significance: Fluctuating or progressive hearing loss in the middle-to-high frequencies may reasonably suggest PLF in the absence of antecedent traumatic events.

Indexed as

antecedent traumatic eventsCochlin-tomoproteinfistula signfluctuating hearing losshigh-frequency hearing lossidiopathic sudden sensorineural hearing lossPerilymphatic fistulaprogressive hearing loss

Identifiers

PMID40297856
PMCPMC12034543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.